[300 Pages Report] The global hemostatic gels market was valued at US$ 957.1 Million in 2021, and is expected to expand at a CAGR of 6.8% to reach US$ 1.9 Billion by 2032. According to a recent study by Future Market Insights, porcine-based hemostatic gels are leading the market with a market share of about 45% in 2021 among the material types.
Data Points
Market Insights
Hemostatic Gels Market Base Year Value (2021)
US$ 957.1 Million
Estimated Market Size (2022)
US$ 1.0 Billion
Projected Market Valuation (2032)
US$ 1.9 Billion
Value-based CAGR (2022 to 2032)
6.8%
Market Share of Top 5 Countries
45.9%
Hemostatic gel is used as an assistant or alternative to hemostat devices to manage bleeding or wound closure. Blood loss is one of the main causes of death in physical trauma. It is important to manage blood loss and achieve quicker clotting than the natural clotting process which is occurred in the body. To achieve blood clotting more quickly, physicians occasionally use hemostatic agents such as a hemostatic gel. These gels may promote clotting and thereby stop or control bleeding.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2017-2021 Hemostatic Gels Market Historic Outlook Vs 2022 to 2032 Forecast
The market value for hemostatic gels was approximately 21.8% of the overall US$ 4.3 Bn of the global hemostats market in 2021. Sales of hemostatic gels increased at a CAGR of 5.4% between 2017 to 2021, owing to the growing volume of surgical procedures.
Growing interest in developing new hemostatic agents is due to unmet needs in modifying uncontrolled hemorrhages in emergency care, surgical procedures, and frontline situations. Even though a wide range of hemostats are available, the development of ideal hemostatic agents such as hemostatic gel formulations that offer including the ability to successfully and instantly manage blood loss, excellent mechanical properties, biocompatibility, antibacterial effect, strong tissue adhesion properties, and biodegradability, under wet and active conditions, remains a challenge.
Benefiting from biocompatibility, high porosity, injectability, and ease of handling, polymeric hydrogels with outstanding hemostatic properties have been receiving consideration over the last decade. Furthermore, the development of novel technologies to cater to the demand for high-quality gel-forming hemostatic agents will drive the overall hemostatic gels market.
The market is projected to witness lucrative growth during forecast period owing to increasing volumes of surgical procedures. According to WHO, annually, a surprising 310 million major surgeries are performed globally; and in U.S. and Europe, approximately 45 and 20 million surgeries are carried out respectively every year. This is attributed to the growing prevalence of obesity and other lifestyle diseases, rising prevalence of orthopaedic disease, and the growing occurrence of spinal and sports-related injuries.
Moreover, in both developed and emerging countries the number of hospitals and surgical centers is growing. The demand for hemostats such as hemostatic gels is high in these newly established hospitals and surgical centers due to the growing patient population base.
For instance, in the last quarter of 2020, U.K. Prime Minister Boris Johnson declared an investment of US4 4.3 Bn for 40 hospitals and certain schemes for upcoming funding for 48 hospitals by 2030.
Also, Steward Health Care in March 2021 announced plans to construct a new hospital in Washington. Thus, owing to the above-mentioned factors, the global hemostatic gels market is expected to grow at a CAGR of 6.8% during the forecast period.
What are the Key Opportunities for Hemostatic Gels Manufacturers?
Hemostasis has high clinical importance in preventive, surgical, and emergency circumstances as blood loss may cause substantial diseases and deaths in civil and military individuals owing to bleeding problems rising from surgery, trauma injuries, and as hereditary, disease-related, or drug-induced blood syndromes.
For externally accessible injuries, a range of natural and synthetic biomaterials have to go through strong research, leading to hemostatic technologies including bandages, dressings, fibrin glues, tourniquets, tamponades, and hemostatic powders.
In contrast, treatment of internal non-compressible hemorrhage still severely relies on transfusion of pure blood or blood hemostatic components such as platelets, coagulation factors, and fibrinogens. Transfusion of platelets may experience significant challenges of high cost, limited availability, contamination risks, short shelf-life, performance variability, low portability, and immunological adverse reactions.
The usage of these blood hemostatic components provides only partial mechanisms for hemostasis. Through such concerns, interdisciplinary research is being conducted for the development of hemostatic gels that can be manufactured conveniently, and administered intravenously to mimic, leverage, and amplify physiological hemostatic mechanisms. This is expected to create opportunities for growth in the market for the development of effective and efficient hemostats.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Insights
What is Driving the U.S. Hemostatic Gels Market?
“Increasing Incidence of Lifestyle Related Disorders is Driving Demand for Hemostatic Gels”
The U.S. dominated the North America hemostatic gels market, accounting for 82% of the total markets share in 2021. Rising prevalence of cardiovascular disorders, diabetes, and cancer in the U.S. is propelling the volume of surgical procedures, thereby necessitating hemostatic gels.
With the global rise in the incidence of chronic diseases, the volume of surgical procedures is expected to increase in the forthcoming years, which is expected to drive demand hemostatic gels for blood loss management.
According to the CDC, around 150 million Americans are suffering from at least one chronic condition, which leads to the need for surgery. With the growing incidence of chronic diseases, the number of injuries and surgeries is expected to increase, thereby increasing the usage of hemostatic gels in the U.S.
What is the India Hemostatic Gels Market Outlook?
“Rising Expenditure on Healthcare Infrastructure Will Augment Sales of Hemostatic Gels”
Demand for hemostatic gels in India is set to increase at a 7.4% CAGR over the assessment period. The market in India is driven by increasing demand for hemostatic gels due to growing government initiatives to create awareness about the product.
For instance, in November 2020, the transport department of the Rajasthan government mandated the addition of feracrylum, a hemostatic gel, in the first aid of all vehicles that are being registered from November 2020 following a direction of the high court. Feracrylum has been recognized to be a hemostatic agent by several clinical studies.
Why the U.K. Hemostatic Gels Market Considered Lucrative?
“Growing Trend of Medical Tourism in the U.K. Will Fuel the Adoption of Hemostatic Gels”
Sales in the U.K. market are projected to increase at a 7.1% CAGR over the forecast period. As per the British heart foundation (UK) and its heart and circulatory disease statistics, in 2019, there has been a substantial surge in the number of cardiac surgeries such as aortic valve replacement and angioplasty in the U.K.
Hemostatic gels have higher application in cardiovascular surgeries due to better clinical outcomes compared to other wound closure techniques. Thus, a growing number of cardiac surgeries is expected to spur demand for effective hemostatic gels in the U.K.
What Makes the China Hemostatic Gels Market Attractive?
“Increaisng Establishment of Hospitals and Ambulatory Centers in China Will Propel Demand for Hemostatic Gels”
China held approximately 38.0% of the East Asia hemostatic gels market in 2021. As per the report, sales are forecast to grow at a 8.0% CAGR through 2032.
The government in China is investing heavily in the construction of healthcare infrastructure such as hospitals and clinics. As per an article published in 2020, China announced an investment of US$ 4.6 Bn for the construction of hospitals in Wuhan.
There are now about 26,000 hospitals in China, more than in any other country; among them 60% are public and 40% are in the private sector. The significant growth in the number of hospitals and surgical centers is expected to boost sales of hemostatic gels.
Category-wise Insights
Which Hemostatic Gel Product Is Driving the Market?
“Sales of Porcine-based Hemostatic Gels to Gain Traction”
Based on product type, the porcine-based hemostatic gels segment held the highest market share of about 45% in 2021. As per the report, demand in the segment is expected to increase at a CAGR of 5.7% by the end of the forecast period. Ease of application, efficacy, biocompatibility, and cost-effectiveness are some of the key benefits offered by porcine-based hemostatic gels.
Which Indication Will Hold a Dominant Share in the Global Hemostatic Gels Market?
“Adoption of Hemostatic Gels for Cardiovascular Surgeries Will Increase”
In terms of indication, demand for hemostatic gels for cardiovascular surgeries will account for 33.1% of the total market share by 2032. Blood loss is one of the most common obstacle in cardiac surgeries, particularly following aortic involvements which leads to extended operating times, increased bleeding, and a higher risk of postoperative morbidity and mortality. The use of hemostatic gels, especially in patients undergoing cardiac surgical procedures, is safe and effective in reducing time to hemostasis, reducing transfusion of blood products, and improving patient outcomes.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competitive Landscape
Leading players operating in the global hemostatic gels market are launching innovative products to meet the demand for a hemostatic gel that can be easily and specifically applied, particularly for irregular fractures where bandages can be difficult, and powders are messy and can cause uneasiness. For instance:
In July 2021, Medcura, Inc., and ASO, LLC collaboratively launched Rapid-Seal, a high-performance, antibacterial hemostatic gel which is available on several e-commerce sites and the shelves at a leading U.S. drugstore chain.
In December 2021, Cresilon, Inc. submitted a 510(k) premarket notification to the U.S. FDA for its registered hemostatic gel which is followed by the successful launch of Cresilon's VETIGEL, an innovative hemostatic gel for the veterinary use.
With several competitors in hemostatic gels manufacturing, the overall market is highly fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships, and collaborations. For instance:
In July 2021, Baxter International Inc. completed the acquisition of CryoLife, Inc. for certain assets related to PerClot, a polysaccharide hemostatic system for US$ 60.8 Mn.
Report Scope
Attributes
Details
Estimated Market Size (2022)
US$ 1 Billion
Projected Market Valuation (2032)
US$ 1.9 Billion
Value-based CAGR (2022-2032)
6.8%
Forecast Period
2017 to 2021
Historical Data Available for
2022 to 2032
Market Analysis
US$ Billion for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
The USA, Canada, Brazil, Mexico, Argentina, the UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, and South Africa
Key Market Segments Covered
Material, Indication, End User, and Region
Key Companies Profiled
Baxter
Bio-Chem LLC
Clinician's Choice Dental Products Inc.
Cresilon, Inc.
DSI Ltd.
ENDOVISION CO., LTD
Ethicon US, LLC
F&A Medical
PrevestDenPro
Septodont
Teleflex Incorporated
Ultradent Products Inc. All
VladMiVa
Medcura, Inc.,
Key Market Segments Covered In Hemostatic Gels Industry Research
By Material:
Bovine-Based
Porcine-Based
Polymer-Based
By Indication:
General Surgery
Dental Surgery
Veterinary Surgery
Cardiovascular Surgery
Orthopaedic Surgery
Others
By End-User:
Hospitals
Speciality Clinics
Veterinary Settings
Ambulatory Surgical Centers
Online Sales
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)
Frequently Asked Questions
How much is the hemostatic gels market worth in 2021?
The global hemostatic gels market is worth US$ 957.1 Mn in 2021 and is set to expand 2.1X over the next ten years.
What is the sales forecast for the hemostatic gels market through 2032?
The hemostatic gels market is expected to reach US$ 1.9 Bn by the end of 2032, with sales revenue expected to register at 6.8% CAGR.
What are the key trends shaping the hemostatic gels industry?
The growing volume of surgical procedures and the increasing need for hemostatic gels in blood loss management are some of the key trends in this market.
Which are the top 5 countries driving demand for hemostatic gels?
The U.S., the U.K., India, China, and Brazil are expected to drive demand for the hemostatic gels industry.
What is the North American market outlook for hemostatic gels?
North America is one of the key markets for hemostatic gels, with the U.S. accounting for about 82% of the North American hemostatic gels market in the year 2021.
At what percentage is the demand for hemostatic gels expected to register growth in Europe?
Demand for hemostatic gels in Europe is expected to register a growth of 7.1% over the next ten years.
Which countries are the key producers of hemostatic gels?
The U.S., the U.K., India, and China are the key producers of hemostatic gels.
Who are the key players in the hemostatic gels market sphere?
Baxter, Bio-Chem LLC, Clinician's Choice Dental Products Inc., Cresilon, Inc., Dsi Ltd., Endovision Co., Ltd, Ethicon US, LLC, F&A Medical, Prevestdenpro, Septodont, Teleflex Incorporated, Ultradent Products Inc. All, Vladmiva And Medcura, Inc., Are Some Of The Key Players In The Hemostatic Gels Industry.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development and Innovation Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Key Promotional Strategies, By Manufacturers
4.3. Pipeline Assessment
4.4. Value Chain Analysis
4.5. Regulatory Landscape
4.6. PESTEL analysis
4.7. Porter’s analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Per Capita Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Demand for Targeted Drug Therapies.
5.2.2. Rapidly Increasing volume of surgical procedures
5.2.3. Rising Prevalence of Chronic Disease
5.2.4. Increasing Investments In R&D
5.2.5. Technological Advancements In Hemostatic Agents
5.2.6. Availability Of Technologically Advanced Products
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis – Impact Assessment
6.1. COVID19 and Impact Analysis
6.1.1. Revenue By Material
6.1.2. Revenue By Indication
6.1.3. Revenue By End User
6.1.4. Revenue By Region
6.2. 2021 Market Scenario
7. Global Hemostatic Gels Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By Material
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Material, 2017–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2022–2032
8.3.1. Bovine Based
8.3.2. Porcine Based
8.3.3. Polymer Based
8.4. Market Attractiveness Analysis By Material
9. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn), By Indication, 2017–2021
9.3. Current and Future Market Size (US$ Mn) and Forecast By Indication, 2022–2032
9.3.1. General Surgery
9.3.2. Dental Surgery
9.3.3. Veterinary Surgery
9.3.4. Cardiovascular Surgery
9.3.5. Orthopedic Surgery
9.3.6. Others
9.4. Market Attractiveness Analysis By Indication
10. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, By End-User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn), By End-User, 2017–2021
10.3. Current and Future Market Size (US$ Mn) and Forecast By End-User, 2022–2032
10.3.1. Hospitals
10.3.2. Speciality Clinics
10.3.3. Veterinary Settings
10.3.4. Ambulatory Surgical Centers
10.3.5. Online Sales
10.4. Market Attractiveness Analysis By End-User
11. Global Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Material
12.3.3. By Indication
12.3.4. By End-User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Material
12.4.3. By Indication
12.4.4. By End-User
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. U.S. Hemostatic Gels Market Analysis
12.7.1.1. .Introduction
12.7.1.2. Market Analysis and Forecast by Market Taxonomy
12.7.1.2.1. By Material
12.7.1.2.2. By Indication
12.7.1.2.3. By End-User
12.7.2. Canada Hemostatic Gels Market Analysis
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast by Market Taxonomy
12.7.2.2.1. By Material
12.7.2.2.2. By Indication
12.7.2.2.3. By End-User
13. Latin America Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Material
13.3.3. By Indication
13.3.4. By End-User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Material
13.4.3. By Indication
13.4.4. By End-User
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. Mexico Hemostatic Gels Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Material
13.7.1.2.2. By Indication
13.7.1.2.3. By End-User
13.7.2. Brazil Hemostatic Gels Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Material
13.7.2.2.2. By Indication
13.7.2.2.3. By End-User
13.7.3. Argentina Hemostatic Gels Market Analysis
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast by Market Taxonomy
13.7.3.2.1. By Material
13.7.3.2.2. By Indication
13.7.3.2.3. By End-User
14. Europe Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Poland
14.3.1.7. Russia
14.3.1.8. Nordic Countries
14.3.1.9. BENULUX
14.3.1.10. Rest of Europe
14.3.2. By Material
14.3.3. By Indication
14.3.4. By End-User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Material
14.4.3. By Indication
14.4.4. By End-User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Hemostatic Gels Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Material
14.8.1.2.2. By Indication
14.8.1.2.3. By End-User
14.8.2. Italy Hemostatic Gels Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Material
14.8.2.2.2. By Indication
14.8.2.2.3. By End-User
14.8.3. France Hemostatic Gels Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Material
14.8.3.2.2. By Indication
14.8.3.2.3. By End-User
14.8.4. U.K. Hemostatic Gels Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Material
14.8.4.2.2. By Indication
14.8.4.2.3. By End-User
14.8.5. Spain Hemostatic Gels Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Material
14.8.5.2.2. By Indication
14.8.5.2.3. By End-User
14.8.6. Poland Hemostatic Gels Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Material
14.8.6.2.2. By Indication
14.8.6.2.3. By End-User
14.8.7. Russia Hemostatic Gels Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Material
14.8.7.2.2. By Indication
14.8.7.2.3. By End-User
14.8.8. Nordic Countries Hemostatic Gels Market Analysis
14.8.8.1. Introduction
14.8.8.2. Market Analysis and Forecast by Market Taxonomy
14.8.8.2.1. By Material
14.8.8.2.2. By Indication
14.8.8.2.3. By End-User
14.8.9. BENELUX Hemostatic Gels Market Analysis
14.8.9.1. Introduction
14.8.9.2. Market Analysis and Forecast by Market Taxonomy
14.8.9.2.1. By Material
14.8.9.2.2. By Indication
14.8.9.2.3. By End-User
15. South Asia Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Material
15.3.3. By Indication
15.3.4. By End-User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Material
15.4.3. By Indication
15.4.4. By End-User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. India Hemostatic Gels Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Material
15.7.1.2.2. By Indication
15.7.1.2.3. By End-User
15.7.2. Indonesia Hemostatic Gels Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Material
15.7.2.2.2. By Indication
15.7.2.2.3. By End-User
15.7.3. Malaysia Hemostatic Gels Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Material
15.7.3.2.2. By Indication
15.7.3.2.3. By End-User
15.7.4. Thailand Hemostatic Gels Market Analysis
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Material
15.7.4.2.2. By Indication
15.7.4.2.3. By End-User
16. East Asia Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By By Material
16.3.3. By Indication
16.3.4. By End-User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Material
16.4.3. By Indication
16.4.4. By End-User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. China Hemostatic Gels Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Material
16.7.1.2.2. By Indication
16.7.1.2.3. By End-User
16.7.2. Japan Hemostatic Gels Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Material
16.7.2.2.2. By Indication
16.7.2.2.3. By End-User
16.7.3. South Korea Hemostatic Gels Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Material
16.7.3.2.2. By Indication
16.7.3.2.3. By End-User
17. Oceania Hemostatic Gels Market 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Material
17.3.3. By Indication
17.3.4. By End-User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Material
17.4.3. By Indication
17.4.4. By End-User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Hemostatic Gels Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Material
17.7.1.2.2. By Indication
17.7.1.2.3. By End-User
17.7.2. New Zealand Hemostatic Gels Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Material
17.7.2.2.2. By Indication
17.7.2.2.3. By End-User
18. Middle East and Africa (MEA) Hemostatic Gels Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2017–2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. Turkey
18.3.1.2. GCC Countries
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Material
18.3.3. By Indication
18.3.4. By End-User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Material
18.4.3. By Indication
18.4.4. By End-User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. Turkey Hemostatic Gels Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Material
18.7.1.2.2. By Indication
18.7.1.2.3. By End-User
18.7.2. GCC Countries Hemostatic Gels Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Material
18.7.2.2.2. By Indication
18.7.2.2.3. By End-User
18.7.3. South Africa & North Africa Hemostatic Gels Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Material
18.7.3.2.2. By Indication
18.7.3.2.3. By End-User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Company Share Analysis
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Market Concentration
20.4. Competition Deep Dive (Tentative List)
20.4.1. Baxter
20.4.1.1.1. Overview
20.4.1.1.2. Product Portfolio
20.4.1.1.3. Key Financials
20.4.1.1.4. Sales Footprint
20.4.1.1.5. Strategy Overview
20.4.2. Bio-Chem LLC
20.4.2.1.1. Overview
20.4.2.1.2. Product Portfolio
20.4.2.1.3. Key Financials
20.4.2.1.4. Sales Footprint
20.4.2.1.5. Strategy Overview
20.4.3. Clinician's Choice Dental Products Inc.
20.4.3.1.1. Overview
20.4.3.1.2. Product Portfolio
20.4.3.1.3. Key Financials
20.4.3.1.4. Sales Footprint
20.4.3.1.5. Strategy Overview
20.4.4. Cresilon –VETIGEL
20.4.4.1.1. Overview
20.4.4.1.2. Product Portfolio
20.4.4.1.3. Key Financials
20.4.4.1.4. Sales Footprint
20.4.4.1.5. Strategy Overview
20.4.5. DSI Ltd.
20.4.5.1.1. Overview
20.4.5.1.2. Product Portfolio
20.4.5.1.3. Key Financials
20.4.5.1.4. Sales Footprint
20.4.5.1.5. Strategy Overview
20.4.6. ENDOVISION CO.,LTD
20.4.6.1.1. Overview
20.4.6.1.2. Product Portfolio
20.4.6.1.3. Key Financials
20.4.6.1.4. Sales Footprint
20.4.6.1.5. Strategy Overview
20.4.7. Ethicon US, LLC
20.4.7.1.1. Overview
20.4.7.1.2. Product Portfolio
20.4.7.1.3. Key Financials
20.4.7.1.4. Sales Footprint
20.4.7.1.5. Strategy Overview
20.4.8. F&A Medical
20.4.8.1.1. Overview
20.4.8.1.2. Product Portfolio
20.4.8.1.3. Key Financials
20.4.8.1.4. Sales Footprint
20.4.8.1.5. Strategy Overview
20.4.9. PrevestDenPro
20.4.9.1.1. Overview
20.4.9.1.2. Product Portfolio
20.4.9.1.3. Key Financials
20.4.9.1.4. Sales Footprint
20.4.9.1.5. Strategy Overview
20.4.10. Septodont
20.4.10.1.1. Overview
20.4.10.1.2. Product Portfolio
20.4.10.1.3. Key Financials
20.4.10.1.4. Sales Footprint
20.4.10.1.5. Strategy Overview
20.4.11. Teleflex Incorporated
20.4.11.1.1. Overview
20.4.11.1.2. Product Portfolio
20.4.11.1.3. Key Financials
20.4.11.1.4. Sales Footprint
20.4.11.1.5. Strategy Overview
20.4.12. Ultradent Products Inc. All
20.4.12.1.1. Overview
20.4.12.1.2. Product Portfolio
20.4.12.1.3. Key Financials
20.4.12.1.4. Sales Footprint
20.4.12.1.5. Strategy Overview
20.4.13. VladMiVa
20.4.13.1.1. Overview
20.4.13.1.2. Product Portfolio
20.4.13.1.3. Key Financials
20.4.13.1.4. Sales Footprint
20.4.13.1.5. Strategy Overview
20.4.14. Medcura, Inc.,
20.4.14.1.1. Overview
20.4.14.1.2. Product Portfolio
20.4.14.1.3. Key Financials
20.4.14.1.4. Sales Footprint
20.4.14.1.5. Strategy Overview
21. Assumptions and Acronyms Used22. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 02: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 03: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 04: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 05: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 06: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 07: Global Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Region
Table 08: Global Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Region
Table 09: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 10: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 11: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 12: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 13: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 14: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 15: North America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 16: North America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 17: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 18: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 19: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 20: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 21: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 22: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 23: Latin America Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 24: Latin America Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 25: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 26: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 27: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 28: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 29: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 30: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 31: Europe Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 32: Europe Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 33: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 34: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 35: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 36: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 37: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 38: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 39: South Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 40: South Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 41: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 42: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 43: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 44: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 45: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 46: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 47: East Asia Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 48: East Asia Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 49: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 50: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 51: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 52: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 53: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 54: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 55: Oceania Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 56: Oceania Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Table 57: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Country
Table 58: Middle East and Africa Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Country
Table 59: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Material
Table 60: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Material
Table 61: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By Indication
Table 62: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By Indication
Table 63: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Analysis 2017–2021, By End User
Table 64: Middle East and Africa (MEA) Hemostatic Gels Market Value (US$ Mn) Opportunity Assessment 2022–2032, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 02: Global Hemostatic Gels Market Value (US$ Mn), 2022 – 2032 & Y-o-Y Growth Trend Analysis
Figure 03: Global Hemostatic Gels Market Absolute $ Opportunity, 2022-2032
Figure 04: Global Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 05: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Material, 2022-2032
Figure 06: Global Hemostatic Gels Market Attractiveness Analysis By Material, 2022-2032
Figure 07: Global Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 08: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Indication, 2022-2032
Figure 09: Global Hemostatic Gels Market Attractiveness Analysis By Indication, 2022-2032
Figure 10: Global Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 11: Global Hemostatic Gels Market Y-o-Y Analysis (%), By End User, 2022-2032
Figure 12: Global Hemostatic Gels Market Attractiveness Analysis by End User, 2022-2032
Figure 13: Global Hemostatic Gels Market Share Analysis (%), By Region, 2021 & 2032
Figure 14: Global Hemostatic Gels Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 15: Global Hemostatic Gels Market Attractiveness Analysis by Region, 2022-2032
Figure 16: North America Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 17: North America Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 18: North America Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 19: North America Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 20: North America Hemostatic Gels Market Value (US$ Mn) Analysis, 2017–2021
Figure 21: North America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 22: North America Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 23: North America Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 24: North America Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 25: North America Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 26: U.S. Market Value Proportion Analysis, 2021
Figure 27: Global Vs U.S. Y-o-Y Growth Comparison, 2021-2032
Figure 28: U.S. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 29: U.S. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 30: U.S. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 31: Canada Market Value Proportion Analysis, 2021
Figure 32: Global Vs Canada Y-o-Y Growth Comparison, 2021-2032
Figure 33: Canada Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 34: Canada Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 35: Canada Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 36: Latin America Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 37: Latin America Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 38: Latin America Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 39: Latin America Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 40: Latin America Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 41: Latin America Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 42: Latin America Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 43: Latin America Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 44: Latin America Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 45: Latin America Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 46: Brazil Market Value Proportion Analysis, 2021
Figure 47: Global Vs Brazil Y-o-Y Growth Comparison, 2021-2032
Figure 48: Brazil Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 49: Brazil Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 50: Brazil Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 51: Mexico Market Value Proportion Analysis, 2021
Figure 52: Global Vs Mexico Y-o-Y Growth Comparison, 2021-2032
Figure 53: Mexico Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 54: Mexico Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 55: Mexico Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 56: Argentina Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Y-o-Y Growth Comparison, 2021-2032
Figure 58: Argentina Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 59: Argentina Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 60: Argentina Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 61: Europe Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 62: Europe Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 63: Europe Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 64: Europe Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 65: Europe Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 66: Europe Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 67: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 68: Europe Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 69: Europe Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 70: Europe Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 71: Germany Market Value Proportion Analysis, 2021
Figure 72: Global Vs Germany Y-o-Y Growth Comparison, 2021-2032
Figure 73: Germany Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 74: Germany Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 75: Germany Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 76: Italy Market Value Proportion Analysis, 2021
Figure 77: Global Vs Italy Y-o-Y Growth Comparison, 2021-2032
Figure 78: Italy Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 79: Italy Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 80: Italy Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 81: France Market Value Proportion Analysis, 2021
Figure 82: Global Vs France Y-o-Y Growth Comparison, 2021-2032
Figure 83: France Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 84: France Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 85: France Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 86: U.K. Market Value Proportion Analysis, 2021
Figure 87: Global Vs U.K. Y-o-Y Growth Comparison, 2021-2032
Figure 88: U.K. Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 89: U.K. Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 90: U.K. Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 91: Spain Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Y-o-Y Growth Comparison, 2021-2032
Figure 93: Spain Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 94: Spain Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 95: Spain Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 96: BENELUX Market Value Proportion Analysis, 2021
Figure 97: Global Vs BENELUX Y-o-Y Growth Comparison, 2021-2032
Figure 98: BENELUX Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 99: BENELUX Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 100: BENELUX Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 101: Russia Market Value Proportion Analysis, 2021
Figure 102: Global Vs Russia Y-o-Y Growth Comparison, 2021-2032
Figure 103: Russia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 104: Russia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 105: Russia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 106: South Asia Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 107: South Asia Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 108: South Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 109: South Asia Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 110: South Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 111: South Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 112: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 113: South Asia Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 114: South Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 115: South Asia Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 116: India Market Value Proportion Analysis, 2021
Figure 117: Global Vs India Y-o-Y Growth Comparison, 2021-2032
Figure 118: India Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 119: India Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 120: India Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 121: Thailand Market Value Proportion Analysis, 2021
Figure 122: Global Vs Thailand Y-o-Y Growth Comparison, 2021-2032
Figure 123: Thailand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 124: Thailand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 125: Thailand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 126: Indonesia Market Value Proportion Analysis, 2021
Figure 127: Global Vs Indonesia Y-o-Y Growth Comparison, 2021-2032
Figure 128: Indonesia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 129: Indonesia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 130: Indonesia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 131: Malaysia Market Value Proportion Analysis, 2021
Figure 132: Global Vs Malaysia Y-o-Y Growth Comparison, 2021-2032
Figure 133: Malaysia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 134: Malaysia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 135: Malaysia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 136: East Asia Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 137: East Asia Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 138: East Asia Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 139: East Asia Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 140: East Asia Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 141: East Asia Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 142: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Country
Figure 143: East Asia Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 144: East Asia Hemostatic Gels Market Market Attractiveness Analysis, By Indication
Figure 145: East Asia Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 146: China Market Value Proportion Analysis, 2021
Figure 147: Global Vs China Y-o-Y Growth Comparison, 2021-2032
Figure 148: China Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 149: China Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 150: China Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 151: Japan Market Value Proportion Analysis, 2021
Figure 152: Global Vs Japan Y-o-Y Growth Comparison, 2021-2032
Figure 153: Japan Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 154: Japan Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 155: Japan Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 156: South Korea Market Value Proportion Analysis, 2021
Figure 157: Global Vs South Korea Y-o-Y Growth Comparison, 2021-2032
Figure 158: South Korea Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 159: South Korea Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 160: South Korea Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 161: Oceania Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 162: Oceania Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 163: Oceania Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 164: Oceania Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 165: Oceania Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 166: Oceania Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 167: Oceania Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 168: Oceania Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 169: Oceania Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 170: Oceania Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 171: Australia Market Value Proportion Analysis, 2021
Figure 172: Global Vs Australia Y-o-Y Growth Comparison, 2021-2032
Figure 173: Australia Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 174: Australia Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 175: Australia Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 176: New Zealand Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Y-o-Y Growth Comparison, 2021-2032
Figure 178: New Zealand Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 179: New Zealand Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 180: New Zealand Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 181: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Country (2022)
Figure 182: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Material (2022)
Figure 183: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By Indication (2022)
Figure 184: Middle East and Africa (MEA) Hemostatic Gels Market Share Analysis (%), By End User (2022)
Figure 185: Middle East and Africa (MEA) Hemostatic Gels Market Historical Market Value (US$ Mn) Analysis, 2017–2021
Figure 186: Middle East and Africa (MEA) Hemostatic Gels Market Current and Future Market Value (US$ Mn), 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 187: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Country
Figure 188: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Material
Figure 189: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By Indication
Figure 190: Middle East and Africa (MEA) Hemostatic Gels Market Attractiveness Analysis, By End User
Figure 191: GCC Countries Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Y-o-Y Growth Comparison, 2021-2032
Figure 193: GCC Countries Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 194: GCC Countries Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 195: GCC Countries Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 196: Turkey Market Value Proportion Analysis, 2021
Figure 197: Global Vs Turkey Y-o-Y Growth Comparison, 2021-2032
Figure 198: Turkey Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 199: Turkey Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 200: Turkey Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 201: North Africa Market Value Proportion Analysis, 2021
Figure 202: Global Vs North Africa Y-o-Y Growth Comparison, 2021-2032
Figure 203: North Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 204: North Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 205: North Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
Figure 206: South Africa Market Value Proportion Analysis, 2021
Figure 207: Global Vs South Africa Y-o-Y Growth Comparison, 2021-2032
Figure 208: South Africa Hemostatic Gels Market Share Analysis (%), By Material, 2021 & 2032
Figure 209: South Africa Hemostatic Gels Market Share Analysis (%), By Indication, 2021 & 2032
Figure 210: South Africa Hemostatic Gels Market Share Analysis (%), By End User, 2021 & 2032
